Anebulo Pharmaceuticals | SCHEDULE 13G:其他
Anebulo Pharmaceuticals | ARS:年度报告
Anebulo Pharmaceuticals | DEF 14A:股东委托书决议
Anebulo Pharmaceuticals | 424B5:募资说明书
Anebulo Pharmaceuticals | EFFECT:其他
Anebulo Pharmaceuticals | SCHEDULE 13D/A:其他
Anebulo Pharmaceuticals | PRE 14A:并购重组委托声明
Anebulo Pharmaceuticals | 8-K:重大事件
Anebulo Pharmaceuticals | S-3:特定交易注册声明
Anebulo Pharmaceuticals | SCHEDULE 13G:其他
Anebulo Pharmaceuticals | 10-Q:2025财年二季报
Anebulo Pharmaceuticals | 8-K:Anebulo Pharmicals公布2025财年第二季度财务业绩和最新动态
Anebulo Pharmaceuticals | 8-K:重大事件
Anebulo Pharmaceuticals | D:发行公告
Anebulo Pharmaceuticals | SCHEDULE 13D/A:其他
Anebulo Pharmaceuticals | 4:持股变动声明-董事 English Aron R.
Anebulo Pharmaceuticals | 8-K:重大事件
Anebulo Pharmaceuticals | 4:持股变动声明-高管 Cunningham, Richard Anthony
Anebulo Pharmaceuticals | 10-Q:2025财年一季报
Anebulo Pharmaceuticals | 8-K:Anebulo Pharmicals公布2025财年第一季度财务业绩和最新动态